Company Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Equities
ANNX BTA
SE0013748894
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- SEK | -.--% | -3.17% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 31/12/13 |
Chief Executive Officer | 63 | 31/12/17 | |
Director of Finance/CFO | 53 | 10/04/23 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 17/01/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 31/12/20 |
Mårten Österlund
BRD | Director/Board Member | 67 | 31/12/20 |
Chief Executive Officer | 63 | 31/12/17 | |
Director/Board Member | 48 | 31/12/16 | |
Director/Board Member | 65 | 31/12/15 | |
Director/Board Member | 66 | 31/12/16 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 31/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 526,807,199 | 256,124,467 ( 48.62 %) | 0 | 48.62 % |
Company contact information
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+4.31% | 22.94B | |
-9.86% | 17.02B | |
-16.47% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |
- Stock Market
- Equities
- ANNX Stock
- ANNX BTA Stock
- Company Annexin Pharmaceuticals AB (publ)